Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
A study that utilized CGMS to determine the pattern of GIH in patients with chronic obstructive pulmonary disease found that GIH occurred 3 to 4 hours post-administration
First, a bacterial reverse mutation test (Ames test) assessed AOD9604s mutagenic potential using four histidine-dependent auxotrophic mutants of Salmonella typhimurium (TA1535, TA1537, TA98, TA100) and one tryptophan-dependent auxotrophic mutant of Escherichia coli (WP2 uvrA), using both plate incorporation and pre-incubation methods at doses of 0, 1.6, 8, 40, 200, 1,000, and 2,000 g AOD9604/plate
Key Features Research Use Only (RUO) compound 50 mg per capsule for consistent research measurement 60 capsules per bottle Encapsulated format for ease of handling in laboratory settings Manufactured and packaged for research applications Product Specifications Compound Name: 5-Amino-1MQ Form: Capsules Dosage Strength: 50 mg per capsule Bottle Size: 60 capsules Grade: Research Use Only (RUO) Intended Use This product is intended solely for laboratory research and investigational purposes
Targeting MET: why, where and how
US$ 21.23
US$ 28.70
US$ 26.68
US$ 24.11
US$ 22.01
